What does D. Western Therapeutics Institute, Inc. do?
D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on discovery and development of various drugs. It offers GLANATEC and GLA-ALPHA, an ophthalmic solution for the treatment of glaucoma/ocular hypertension; H-1337, a multi-kinase inhibitor that has started Phase IIb clinical trials for the…
What is D. Western Therapeutics Institute, Inc.'s P/E and P/B ratio?
D. Western Therapeutics Institute, Inc. has a P/E ratio of -5.2 and a P/B ratio of 2.53.
What is D. Western Therapeutics Institute, Inc.'s debt-to-equity ratio?
D. Western Therapeutics Institute, Inc. has a debt-to-equity ratio of 0.41.
How much does D. Western Therapeutics Institute, Inc. owe compared with what it owns?
D. Western Therapeutics Institute, Inc. owes ¥0.31 for every ¥1 it owns (balance sheet Jun 2026), which is low.
What is D. Western Therapeutics Institute, Inc.'s Positivity rank?
D. Western Therapeutics Institute, Inc. is ranked #7,922 of 10,750 companies globally and #3,342 of 3,683 in Japan on PositoAI, with a Positivity Score of 19,614.
Does D. Western Therapeutics Institute, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Red flags (PosiRed) are not checked yet for companies in this market on PositoAI, so no result is shown for D. Western Therapeutics Institute, Inc..
Where can I read the latest news about D. Western Therapeutics Institute, Inc.?
Recent headlines about D. Western Therapeutics Institute, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does D. Western Therapeutics Institute, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of D. Western Therapeutics Institute, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.